AgingResearch.NewsJoin free

Glutaminolysis inhibitor

Glutaminolysis inhibitor has been studied in 1 paper since 2022: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Nov 29, 2022: “Inhibition of glutaminolysis restores mitochondrial function in senescent stem cells”.

Intervention

1 paper studies it1 findingUpdated

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: National Institute on Aging and 2 more
  • Cells1

What did studies of Glutaminolysis inhibitor find?

1

Studies of Glutaminolysis inhibitor measured 1 outcome; the most studied are mitochondrial respiratory chain activity (1 study).

Mitochondrial respiratory chain activity

upin mice1

1 study

  1. Glutaminolysis inhibitor improves mitochondrial respiratory chain activity in mice.

    “Inhibition of glutaminolysis in progeria mice improves mitochondrial respiratory chain activity”

    Animalsin progeria mice

    Inhibition of glutaminolysis restores mitochondrial function in senescent stem cells

    Cell reports

More on Mitochondrial respiratory chain activity

Latest

Related